Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Annals of the Rheumatic Diseases (ARD)
Published October 22, 2026
Type I interferon activation in classical monocytes and GZMK+ CD8+ T cells characterises the ultr...
October 24, 2026
Medspoke
Medspoke
Annals of the Rheumatic Diseases (ARD)
Published October 23, 2026
00:00
--:--
Emerging drugs in phase 2/3 and selected phase 1/2 cellular-therapy trials: a glimpse into the fu...
October 24, 2026
Share
Emerging drugs in phase 2/3 and selected phase 1/2 cellular-therapy trials: a glimpse into the future of systemic sclerosis treatment.
https://www.medspoke.co/channel_journal?id=688&tap_id=16252
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Rheumatology (Oxford)
Published October 23, 2026
Epidemiology, autoimmune overlap and in-hospital outcomes of idiopathic inflammatory myopathies i...
October 24, 2026
Why are you reporting this TALK?
